{"id":"https://openalex.org/A5120152015","orcid":null,"observed_orcids":[],"display_name":"Linda Ifunanya Odo","raw_author_names":["Linda Ifunanya Odo"],"full_name":"Linda Ifunanya Odo","works_count":1,"cited_by_count":2,"summary_stats":{"2yr_mean_citedness":2.0,"h_index":1,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5120152015","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I11892038","ror":"https://ror.org/01sn1yx84","display_name":"University of Nigeria","country_code":"NG","type":"education","lineage":["https://openalex.org/I11892038"]},"years":[2025]}],"last_known_institutions":[{"id":"https://openalex.org/I11892038","ror":"https://ror.org/01sn1yx84","display_name":"University of Nigeria","country_code":"NG","type":"education","lineage":["https://openalex.org/I11892038"]}],"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","count":1,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","count":1,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11826","display_name":"Ocular Infections and Treatments","count":1,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11826","display_name":"Ocular Infections and Treatments","value":4.3e-06,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","value":2.7e-06,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","value":2.5e-06,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"x_concepts":[{"id":"181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","score":0.41620001196861267},{"id":"177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","score":0.4108000099658966},{"id":"126511603","wikidata":"https://www.wikidata.org/wiki/Q1261145","display_name":"Targeted drug delivery","score":0.2639000117778778},{"id":"16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","score":0.2606000006198883},{"id":"118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","score":0.2556999921798706}],"counts_by_year":[{"year":2025,"works_count":1,"oa_works_count":0,"cited_by_count":2}],"display_name_alternatives":["Linda Ifunanya Odo"],"block_key":"l odo","works_api_url":"https://api.openalex.org/works?filter=author.id:A5120152015","updated_date":"2026-10-10T12:59:14","created_date":"2025-10-28T00:00:00"}